Menu
Recruiting NCT07071298

AERA Pediatrics Registry

Observational Dysfunction of Eustachian Tube

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to
Registry conditions: Dysfunction of Eustachian Tube. Basic parameters: up to 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

A Real World, Observational Pediatric Registry of the Acclarent AERA® Eustachian Tube Balloon Dilation System

Overview

Prospective, multi-center, observational, real-world evidence data collection registry to confirm the continued clinical performance of the AERA® device in pediatric patients

Primary outcome measures

  • Failure-free after ETBD with the AERA® device. [Time frame: 27 months]
Secondary outcome measures (6)
  • Tympanogram assessed by ear [Time frame: 27 months]
  • Pure tone audiometry (PTA) assessed by ear [Time frame: 27 months]
  • Valsalva maneuver assessed by ear [Time frame: 27 months]
  • Inflammation score assessed by ear [Time frame: 27 months]
  • Eustachian Tube Dysfunction Questionnaire (ETDQ-7) assessed by patient [Time frame: 27 months]
  • Otitis Media- 6 Questionnaire (OM-6) assessed by patient [Time frame: 27 months]

Eligibility criteria

Inclusion criteria

  • Age <18
  • Specific indications for ETBD are documented
  • ETBD with AERA device attempted-

Exclusion criteria

  • ETBD with device other than AERA®
  • Previous ETBD procedure-

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Case-only

Study locations

United States · 9 centers
  • Stanford University — Palo Alto
  • Boston Children's Hospital — Boston
  • Michigan Pediatric ENT Associates — West Bloomfield
  • Children's Minnesota — Minneapolis
  • Cincinnati Children's Hospital Medical Center — Cincinnati
  • Children's Hospital of Philadelphia — Philadelphia
  • Ear and Sinus Institute — Fort Worth
  • Texas Children's Hospital — Houston
  • … and 1 more center

Identifiers

NCT: NCT07071298 · C-AERA-P-001

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗